Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.39 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.39 |
| ▸ | BID | P55957 | 3/20 | 0.37 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.37 |
| ▸ | BCL2L1 | Q07817 | 2/20 | 0.37 |
| ▸ | BAK1 | Q16611 | 2/20 | 0.37 |
| ▸ | KAT8 | Q9H7Z6 | 2/20 | 0.37 |
| ▸ | PPARG | P37231 | 2/20 | 0.37 |
| ▸ | PPARA | Q07869 | 2/20 | 0.37 |
| ▸ | IAPP | P10997 | 1/20 | 0.37 |
| ▸ | EP300 | Q09472 | 1/20 | 0.37 |
| ▸ | KAT2A | Q92830 | 1/20 | 0.37 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.37 |
| ▸ | KAT5 | Q92993 | 1/20 | 0.37 |
| ▸ | SAE1 | Q9UBE0 | 1/20 | 0.37 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | FAAH | O00519 | 6/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3187499 | 0.93 | USP2 (0.37) | PPARGPPARAIAPPUSP2 | |
| SCHEMBL3180640 | 0.89 | GABRA1 (0.45) | USP2 | |
| SCHEMBL3174771 | 0.83 | USP2 (0.41) | USP2 | |
| SCHEMBL3173883 | 0.82 | GABRA1 (0.48) | USP2 | |
| SCHEMBL3258406 | 0.81 | GABRA1 (0.42) | ALOX5PTGS2PPARGPPARAIAPP | |
| SCHEMBL3178982 | 0.80 | PPARD (0.45) | PPARGPPARAFAAH | |
| SCHEMBL3190724 | 0.80 | HPGD (0.37) | MCL1USP2FAAH | |
| SCHEMBL4332057 | 0.79 | IAPP (0.44) | ALOX5PTGS2BIDMCL1BCL2L1 | |
| SCHEMBL3258418 | 0.77 | GABRA1 (0.55) | IAPP | |
| SCHEMBL2165406 | 0.77 | HMGB1 (0.51) | ALOX5PTGS2BIDMCL1BCL2L1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8952189-B2 | Process for preparing diaryl carbonates or alkyl aryl carbonates from dialkyl carbonates | BAYER MATERIALSCIENCE AG (DE) | 2015-02-10 | — | — | US | disclosed |
| US-20100261928-A1 | PROCESS FOR PREPARING DIARYL CARBONATES OR ALKYL ARYL CARBONATES FROM DIALKYL CARBONATES | BAYER MATERIALSCIENCE AG (DE) | 2010-10-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100261928-A1 | PROCESS FOR PREPARING DIARYL CARBONATES OR ALKYL ARYL CARBONATES FROM DIALKYL CARBONATES | HDHD5, AHR, AGL | ALOX5 2164/4885PTGS2 3717/4885BID 2085/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.